✦ LIBER ✦

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

✍ Scribed by Beatriz Grinsztejn; Bach-Yen Nguyen; Christine Katlama; Jose M Gatell; Adriano Lazzarin; Daniel Vittecoq; Charles J Gonzalez; Joshua Chen; Charlotte M Harvey; Robin D Isaacs

Book ID: 117301019
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 179 KB
Volume: 369
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(07)60597-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of raltegravir-based

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

✍ Jeffrey L Lennox; Edwin DeJesus; Adriano Lazzarin; Richard B Pollard; Jose Valde 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 248 KB

Efficacy and safety of once daily elvite

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

✍ Jean-Michel Molina; Anthony LaMarca; Jaime Andrade-Villanueva; Bonaventura Clote 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 209 KB

Efficacy and safety of TMC125 (etravirin

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

✍ José Valdez Madruga; Pedro Cahn; Beatriz Grinsztejn; Richard Haubrich; Jacob Lal 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Efficacy and safety of darunavir-ritonav

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

✍ José Valdez Madruga; Daniel Berger; Marilyn McMurchie; Fredy Suter; Denes Banheg 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Efficacy and safety of TMC125 (etravirin

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

✍ Adriano Lazzarin; Thomas Campbell; Bonaventura Clotet; Margaret Johnson; Christi 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

A randomised, placebo-controlled, double

A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

✍ Marco Cicardi; Roberto Perricone; Mauro Cancian; Vincenzo Montinaro; Enrico Cill 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 86 KB